中文摘要：

目的：评价上海市实施国家基本药物制度对各类药品企业的损益影响。方法：分析上海市国家基本药物制度实施前后基层销售市场和非基层销售市场的药品价格变化、药品销售量变化和药品销售总额变化;比较不同类型药品企业销售情况的变化。结果与结论：国家基本药物制度实施后,2011年下半年药品标化加权供应价格降低了6.03%,但由于社区卫生服务中心更多地使用价格较高的药品,造成2011年下半年药品加权供应价格实际升高1.41%的现象;基层销售市场药品销售总量下滑趋势被遏制,销售总金额增加了3.72%;特大型企业受益,其他原市场份额较大企业的销售金额变化与原市场份额位序无显著关系,个别小市场份额企业销售额激增;本地医药企业的销售总金额下降16.97%,外地医药企业增长9.50%,相对受益。

英文摘要：

OBJECTIVE：To evaluate the profit and loss of pharmaceutical enterprises after the implementation of national essential drug system in Shanghai.METHODS：The changes of prices,consumption amount and sum of medicines both in grass-root sales market and non-grass-root sales market were analyzed after the implementation of national essential drug system;the sales changes of different types of enterprises were compared.RESULTS CONCLUSION：After the implementation of national essential drug system in Shanghai,the supply price of medicine which is weighted and standardized in the second half of 2011 has reduced by 6.03%.But actually the weighted supply price has increased by 1.41% because most of high price medicines are used in community health service center.Total consumption sum of grass-root sales market has increased by 3.72% when the declining of grass-root market＇s sales has been reversed.The national essential drug system benefit extra large enterprises;the changes of consumption sum in other enterprises which has large original market share have no related to its rank of sales amount;several enterprises with little original market share surge in consumption sum.The consumption sum of local pharmaceutical enterprises decrease by 16.97%,while that of non-local pharmaceutical enterprises increase by 9.50% which benefited more from national essential drug system.